# A Clinical Research Study to Determine Whether PD 0332991 May Be Effective in Treating Patients With Liver Cancer

> **NCT01356628** · PHASE2 · COMPLETED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University** · enrollment: 23 (actual)

## Conditions studied

- Advanced Hepatocellular Carcinoma
- HCC
- Liver Cancer

## Interventions

- **DRUG:** PD-0332991

## Key facts

- **NCT ID:** NCT01356628
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05-25
- **Primary completion:** 2023-06-01
- **Final completion:** 2023-12-16
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2025-07-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01356628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01356628, "A Clinical Research Study to Determine Whether PD 0332991 May Be Effective in Treating Patients With Liver Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01356628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*